Reuters01-12
PARIS, Jan 12 (Reuters) - France's finance ministry has received no request seeking investment approval in Abivax ABVX.PA and has had no contact with Eli Lilly LLY.N, a ministry official said on Monday, following media reports that the U.S. pharma giant was still interested in buying the French biotech firm.
(Reporting by Mathieu Rosemain, writing by Louise Rasmussen, editing by Benoit Van Overstraeten)
((Louisebreusch.rasmussen@tr.com; +45 21 27 97 79;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
